News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Shire fined $350m for skin product bribes Settlement relates to investigation into Dermagraft sales.
News Intercept's Ocaliva approved in EU for liver disease Potential liver blockbuster gets EU licence.
News NICE rejects Shire pancreatic cancer drug Onivyde not eligible for Cancer Drugs Fund, says NICE.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
